Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 1997

View Archived Issues

Combination of MKC-442, zidovudine and lamivudine highly effective in vitro

Combined blockade of 5-HT1A and 5-HT1B receptors potentiates fluoxetine activity

Positive clinical results for amylin analogue in diabetes

Myriad Genetics granted patent on MTS1 melanoma gene

New antitumor agents from Banyu

Analgesics reported by Daiichi and Fuji

Kyowa Hakko claims analgesic agents

Potent and selective ETA antagonists from Shionogi

Positive phase II results for Hycamtin in small cell lung cancer

N-Oxide oxazolidinones from Pharmacia & Upjohn

Novel semisynthetic macrolide immunosuppressants disclosed by Abbott

nAChR ligands prepared by Novo Nordisk

Warner-Lambert reveals agents with dual dopaminergic/serotonergic activity

British Biotech and SynPhar sign research collaboration

Kowa/Vrije University researchers identify potent CysLT1 receptor antagonists

Cell Genesys files IND for cancer gene therapy

BioChem Pharma's BCH-4556 to enter U.S. phase I trial in cancer

Immunomedics files IND for humanized lymphoma antibody

Rotterdam study assesses risk factors for dementia and AD

SmithKline Beecham's Androderm now available as a single patch system

Population-based study of postmenopausal ERT and risk of AD

Gene Logic and Johns Hopkins University enter into research collaboration

CombiChem and Teijin extend collaborative agreement

Riboflavin shows promise for migraine prophylaxis

Genentech plans phase III studies of second-generation t-PA

Alniditan more effective than sumatriptan in animal model of migraine

BioCryst receives milestone payment from Torii

Phase I/II prostate cancer studies under way for DUROS leuprolide

Fosamax cleared as preventive medication in osteoporosis

ANDA filed for Biovail generic calcium channel blocker

FDA clears generic antidepressant from Teva

DEA recommends descheduling of Redux

Nicotine inhaler cleared by FDA